BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25761846)

  • 1. Has hypofractionated radiotherapy become the standard of care in pediatric DIPG?
    Zaghloul MS
    Childs Nerv Syst; 2015 Aug; 31(8):1221-2. PubMed ID: 25761846
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring the pons: a non-invasive biomarker for pediatric diffuse intrinsic pontine glioma.
    Warren KE
    CNS Oncol; 2014 May; 3(3):181-3. PubMed ID: 25055124
    [No Abstract]   [Full Text] [Related]  

  • 3. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
    Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.
    Infinger LK; Stevenson CB
    Curr Neuropharmacol; 2017; 15(1):129-133. PubMed ID: 27109746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue sampling in diffuse intrinsic pontine glioma (DIPG) at progression.
    CastaƱeda Heredia A; Puerta Roldan P; Guillen Quesada A; Sunol Capella M; de Torres Gomez-Pallete C; Muchart J; Cruz Martinez O; Mora J; Morales La Madrid A
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233413
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffuse intrinsic pontine glioma in children and adolescents: a single-center experience.
    Vallero SG; Bertin D; Basso ME; Pittana LS; Mussano A; Fagioli F
    Childs Nerv Syst; 2014 Jun; 30(6):1061-6. PubMed ID: 24420674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of the pons as a biomarker of progression for pediatric DIPG.
    Steffen-Smith EA; Baker EH; Venzon D; Shandilya S; Bent RS; Warren KE
    J Neurooncol; 2014 Jan; 116(1):127-33. PubMed ID: 24113877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pontine glioma.
    Dunkel IJ; Souweidane MM
    J Neurosurg Pediatr; 2009 Apr; 3(4):257; author reply 257-8. PubMed ID: 19338402
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply: The Optimal Dose of Hypofractionated Radiotherapy in Diffuse Intrinsic Pontine Glioma (DIPG).
    Hankinson TC; Liu AK
    Pediatr Blood Cancer; 2016 May; 63(5):949. PubMed ID: 26840880
    [No Abstract]   [Full Text] [Related]  

  • 10. Brainstem glioma: a review.
    Grimm SA; Chamberlain MC
    Curr Neurol Neurosci Rep; 2013 May; 13(5):346. PubMed ID: 23512689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse intrinsic pontine gliomas: treatments and controversies.
    Bredlau AL; Korones DN
    Adv Cancer Res; 2014; 121():235-259. PubMed ID: 24889533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse intrinsic pontine glioma: time for therapeutic optimism.
    Khatua S; Zaky W
    CNS Oncol; 2014; 3(5):337-48. PubMed ID: 25363006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.
    Bredlau AL; Dixit S; Chen C; Broome AM
    Curr Neuropharmacol; 2017; 15(1):104-115. PubMed ID: 26903150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response.
    Chittiboina P; Lonser RR
    J Neurosurg Pediatr; 2014 Mar; 13(3):274-5. PubMed ID: 24724188
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Convection-enhanced delivery for diffuse intrinsic pontine glioma.
    Souweidane MM
    J Neurosurg Pediatr; 2014 Mar; 13(3):273-4. PubMed ID: 24410123
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
    Hennika T; Becher OJ
    J Child Neurol; 2016 Oct; 31(12):1377-85. PubMed ID: 26374787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons.
    Hankinson TC; Campagna EJ; Foreman NK; Handler MH
    J Neurosurg Pediatr; 2011 Jul; 8(1):97-102. PubMed ID: 21721895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
    Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
    J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric low grade focal brainstem glioma: outcomes of different treatment strategies and prognostic factors.
    Elmaraghi C; Bishr MK; Mousa AG; Ahmed S; Refaat A; Elhemaly A; Ayadi ME; Taha H; Maher E; Elbeltagy M; Zaghloul MS
    Future Oncol; 2020 Oct; 16(30):2401-2410. PubMed ID: 32687387
    [No Abstract]   [Full Text] [Related]  

  • 20. Interdisciplinary care of children with diffuse midline glioma.
    Coleman C; Chen K; Lu A; Seashore E; Stoller S; Davis T; Braunstein S; Gupta N; Mueller S
    Neoplasia; 2023 Jan; 35():100851. PubMed ID: 36410226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.